BioMarin’s hemophilia treatment had only one US patient last year, as drug pioneers discover that scientific achievement doesn’t guarantee financial success.
BioMarin’s hemophilia treatment had only one US patient last year, as drug pioneers discover that scientific achievement doesn’t guarantee financial success.
Comments are closed.